Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study.
about
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II studyPaclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial.Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II studyA randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3).A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors.Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancerCombination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancerPhase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.Combination of gemcitabine and cisplatin as first-line therapy in advanced non-small-cell lung cancerA 21-day schedule of gemcitabine and cisplatin administration in the treatment of advanced non-small cell lung carcinoma: a phase II studyPhase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.[A meta analysis of gemcitabine plus platinum chemotherapy compared with single-agent chemotherapy in the treatment of non-small cell lung cancer].A phase II first-line study of gemcitabine, carboplatin, and bevacizumab in advanced stage nonsquamous non-small cell lung cancer.Paclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials.Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.The role of gemcitabine in the treatment of other tumoursGemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?Role of gemcitabine in cancer therapy.Phase I study of gemcitabine using a once every 2 weeks schedule.A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.Importance of dose intensity in treatment of advanced non-small cell lung cancer in the elderly.Present standards and future perspectives in the treatment of metastatic non-small cell lung cancer.Combined therapy with topotecan and gemcitabine in patients with inoperable or metastatic non-small cell lung cancer.Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study.Is gemcitabine cost effective in cancer treatment?A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer.Synergistic effect of sequential administration of mitoguazone (MGBG) and gemcitabine in treating tissue cultured human breast cancer cells and mammary rat tumors.A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial.
P2860
Q28364203-1BB9FA60-0539-4A44-80D1-FF4FA9E72A50Q31791219-CE20C513-040E-42EC-8A7D-AA9D4234F2FDQ33330549-3D628AF2-5199-4872-B7CB-DDBAFE697504Q33331901-B39EE11D-CE7C-4AFC-A4C4-4AB207EB273BQ33334777-8D6A22BD-0EF3-4107-8308-F8A91EED85E4Q33338157-29CE4BDE-3098-4777-BBDA-2CF9A5F9A9C0Q33338244-84650C32-4015-465B-AB7B-A1009A82C27EQ33346610-61E6ABA5-F3A1-49D8-98E6-B65A737EBD41Q33360840-DC683BEA-D001-4F4F-8404-B00A5DF9FFCCQ33366782-E488347A-CBF3-497A-BDFC-4FF0D9C5060AQ33389157-1C68E04D-9932-4151-91E7-D546485CDC4FQ33389166-23EB7EBC-8688-4007-810A-434143A8C87BQ33389186-E2BBF281-322A-428D-B9FF-B29D48376B35Q33391099-A46F6E88-BF8E-44F1-AE44-B269A63471F6Q33392085-C23778E8-E6AB-407E-99A8-D2828253FE91Q33404683-3E1A563D-3E68-4BBB-9922-AF8AC9CBB2DCQ34517532-F0E2FC6D-B21B-4E97-B108-0925135CD940Q34982142-53710915-CC65-4385-AD21-A2B50E07A215Q36114500-68C66BA7-F61C-4CAE-BB73-A03A4334916DQ36381261-F98675B2-0809-46A4-A068-1BDBB7480E2CQ36429373-DA918DC0-53B0-4294-A25E-C466DF6D3EF4Q36431498-ADD8B4D9-9F6B-4E18-ACC0-979A0F642B4FQ36644598-4D80F84C-67C3-4ABC-A079-B935748D2802Q36671151-C85E0772-BA57-4630-9FE9-6E74AB2C42DBQ38458066-EEFED663-89D4-4B97-B512-9BA08933DF63Q38481104-6BD274FB-C3B4-480A-9AF1-DB276F50A979Q40628014-F24D44EB-3CBB-4EA3-9899-FDF5A5E662E0Q40754903-3ED954CB-DD5A-4588-B939-48B72E393199Q43042833-B559423F-4B55-4858-AFAB-886D66C43E2EQ43260541-11714D8D-A1C7-4E58-A2AF-02BC8E09B589Q44003032-F3824B64-F313-46D3-AEA8-0BF084E02A6BQ44066033-85043795-0A43-4C69-AF7D-5C57C9F3B8A8Q44439083-0CE1F05A-2EBE-416B-9282-20A1A3191E78Q47715936-70FC37E0-F6AE-4778-9F69-F62B19EB0473Q53555247-706B300E-601E-462B-B8A0-527EFBEF344F
P2860
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Activity of gemcitabine in pat ...... ntre, extended phase II study.
@en
type
label
Activity of gemcitabine in pat ...... ntre, extended phase II study.
@en
prefLabel
Activity of gemcitabine in pat ...... ntre, extended phase II study.
@en
P2093
P1476
Activity of gemcitabine in pat ...... ntre, extended phase II study.
@en
P2093
F A Shepherd
H Cortes-Funes
M Gottfried
P Weynants
R L Burkes
P304
P356
10.1016/0959-8049(95)00444-0
P577
1996-02-01T00:00:00Z